These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 9264085

  • 1. The behavioral effects of NMDA antagonists in serotonin depleted rats.
    Płaźnik A, Jessa M, Nazar M.
    Pharmacol Biochem Behav; 1997 Sep; 58(1):159-66. PubMed ID: 9264085
    [Abstract] [Full Text] [Related]

  • 2. The impact of a competitive and a non-competitive NMDA receptor antagonist on dopaminergic neurotransmission in the rat ventral tegmental area and substantia nigra.
    Wedzony K, Czyrak A, Maćkowiak M, Fijał K.
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):517-27. PubMed ID: 8740145
    [Abstract] [Full Text] [Related]

  • 3. Discriminative stimulus effects of the NMDA receptor antagonists MK-801 and CGP 37849 in rats.
    Zajaczkowski W, Moryl E, Papp M.
    Pharmacol Biochem Behav; 1996 Sep; 55(1):163-8. PubMed ID: 8870053
    [Abstract] [Full Text] [Related]

  • 4. Effects of antagonists at the NMDA receptor complex in two models of anxiety.
    Plaznik A, Palejko W, Nazar M, Jessa M.
    Eur Neuropsychopharmacol; 1994 Dec; 4(4):503-12. PubMed ID: 7894261
    [Abstract] [Full Text] [Related]

  • 5. The competitive NMDA antagonists CGP 43487 and APV potentiate dopaminergic function.
    Dall'Olio R, Rimondini R, Gandolfi O.
    Psychopharmacology (Berl); 1995 Apr; 118(3):310-5. PubMed ID: 7617824
    [Abstract] [Full Text] [Related]

  • 6. Brain serotonin depletion by lesions of the median raphe nucleus enhances the psychotomimetic action of phencyclidine, but not dizocilpine (MK-801), in rats.
    Kusljic S, Brosda J, Norman TR, van den Buuse M.
    Brain Res; 2005 Jul 12; 1049(2):217-26. PubMed ID: 15953591
    [Abstract] [Full Text] [Related]

  • 7. Comparison of competitive and uncompetitive NMDA receptor antagonists with regard to monoaminergic neuronal activity and behavioural effects in rats.
    Löscher W, Annies R, Hönack D.
    Eur J Pharmacol; 1993 Oct 05; 242(3):263-74. PubMed ID: 7904243
    [Abstract] [Full Text] [Related]

  • 8. The non-competitive NMDA receptor blocker dizocilpine potentiates serotonergic function.
    Dall'Olio R, Gaggi R, Bonfante V, Gandolfi O.
    Behav Pharmacol; 1999 Feb 05; 10(1):63-71. PubMed ID: 10780303
    [Abstract] [Full Text] [Related]

  • 9. Anticonflict effects of a competitive NMDA receptor antagonist and a partial agonist at strychnine-insensitive glycine receptors.
    Przegaliński E, Tatarczyńska E, Dereń-Wesołek A, Chojnacka-Wójcik E.
    Pharmacol Biochem Behav; 1996 May 05; 54(1):73-7. PubMed ID: 8728541
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The effects of repeated administration of diazepam, MK-801 and CGP 37849 on rat behavior in two models of anxiety.
    Jessa M, Nazar M, Bidzinski A, Plaznik A.
    Eur Neuropsychopharmacol; 1996 Mar 05; 6(1):55-61. PubMed ID: 8866939
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Anticonvulsant and behavioral effects of two novel competitive N-methyl-D-aspartic acid receptor antagonists, CGP 37849 and CGP 39551, in the kindling model of epilepsy. Comparison with MK-801 and carbamazepine.
    Löscher W, Hönack D.
    J Pharmacol Exp Ther; 1991 Feb 05; 256(2):432-40. PubMed ID: 1671593
    [Abstract] [Full Text] [Related]

  • 14. NMDA receptor antagonists change behavioral activity of rats treated with (S)-4CPG.
    Car H, Oksztel R, Nadlewska A, Wiśniewski K.
    Pol J Pharmacol; 2001 Feb 05; 53(4):331-9. PubMed ID: 11990079
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Locomotor activity and motor disturbances induced by the competitive NMDA receptor antagonist CGP 37849.
    Kolasiewicz W, Maj J.
    Pol J Pharmacol; 1996 Feb 05; 48(5):467-79. PubMed ID: 9112688
    [Abstract] [Full Text] [Related]

  • 17. Modulation of the mesolimbic dopamine system by glutamate: role of NMDA receptors.
    Kretschmer BD.
    J Neurochem; 1999 Aug 05; 73(2):839-48. PubMed ID: 10428083
    [Abstract] [Full Text] [Related]

  • 18. A competitive antagonist of NMDA receptors CGP 40116 attenuates experimental symptoms of schizophrenia evoked by MK-801.
    Zajaczkowski W, Czyrak A, Wedzony K.
    Pol J Pharmacol; 2003 Aug 05; 55(5):703-11. PubMed ID: 14704466
    [Abstract] [Full Text] [Related]

  • 19. NMDA receptor antagonists impair motor performance in immature rats.
    Mikulecká A, Mares P.
    Psychopharmacology (Berl); 2002 Aug 05; 162(4):364-72. PubMed ID: 12172689
    [Abstract] [Full Text] [Related]

  • 20. Competitive NMDA receptor antagonists do not produce locomotor hyperactivity by a dopamine-dependent mechanism.
    Ouagazzal A, Amalric M.
    Eur J Pharmacol; 1995 Dec 27; 294(1):137-46. PubMed ID: 8788425
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.